FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

REMS Document Technical Conformance Guide

FDA publishes a technical conformance guide for its guidance on the format and content of a REMS document.

latest-news-card-1
Medical Devices

Jet Medical, Other Companies, Pay $700,000 in Device Cases

Jet Medical and two related companies agree to pay $700,000 to resolve criminal and civil charges involving Jets distribution of unapproved medical de...

latest-news-card-1
Human Drugs

Checkpoint Therapeutics BLA for Skin Cancer

Checkpoint Therapeutics files a BLA for cosibelimab, an investigational anti-PD-L1 antibody for treating patients with metastatic cutaneous squamous c...

latest-news-card-1
Medical Devices

Medical Device Consensus Standards Database Updated

FDA updates the CDRH Recognized Consensus Standards database, adding List 59.

latest-news-card-1
Human Drugs

FDA Changes Mifepristone REMS

FDA modifies the mifepristone REMS to remove the in-person dispensing requirement and permit dispensing by certified pharmacies.

latest-news-card-1
FDA General

FDA Reforms Included in Year-end Omnibus Bill

In addition to a $226 million boost in FDA spending levels, the year-end omnibus spending bill also includes notable agency reforms that were once par...

latest-news-card-1
Human Drugs

Accord Healthcare Recalls 2 Daptomycin Products

FDA says Accord Healthcare recalled one lot of daptomycin for injection due to a labeling mix-up.

latest-news-card-1
Human Drugs

FDA Approves Acers Olpruva for Urea Cycle Disorders

FDA approves a resubmitted Acer Therapeutics NDA for its Olpruva to treat some patients with urea cycle disorders.

Medical Devices

RoyalVibe Health Refused Inspection: FDA

FDA warns The Woodlands, TX-based RoyalVibe Health about manufacturing, marketing, and distributing unapproved medical devices that are misbranded and...

Human Drugs

Inspection Issues at Sagents Plattsburgh Facility

FDA warns Sagent Pharmaceuticals about issues found in an inspection at its Plattsburg, NY-based sterile drug products manufacturing facility.